Arteriovenous malformation in the adult mouse brain resembling the human disease
- PMID: 21437931
- PMCID: PMC3117949
- DOI: 10.1002/ana.22348
Arteriovenous malformation in the adult mouse brain resembling the human disease
Abstract
Objective: Brain arteriovenous malformations (bAVMs) are an important cause of hemorrhagic stroke. The underlying mechanisms are not clear. No animal model for adult bAVM is available for mechanistic exploration. Patients with hereditary hemorrhagic telangiectasia type 2 (HHT2) with activin receptor-like kinase 1 (ALK1; ACVRL1) mutations have a higher incidence of bAVM than the general population. We tested the hypothesis that vascular endothelial growth factor (VEGF) stimulation with regional homozygous deletion of Alk1 induces severe dysplasia in the adult mouse brain, akin to human bAVM.
Methods: Alk1(2f/2f) (exons 4-6 flanked by loxP sites) and wild-type (WT) mice (8-10 weeks old) were injected with adenoviral vector expressing Cre recombinase (Ad-Cre; 2 × 10(7) plaque forming units [PFU]) and adeno-associated viral vectors expressing VEGF (AAV-VEGF; 2 × 10(9) genome copies) into the basal ganglia. At 8 weeks, blood vessels were analyzed.
Results: Gross vascular irregularities were seen in Alk1(2f/2f) mouse brain injected with Ad-Cre and AAV-VEGF. The vessels were markedly enlarged with abnormal patterning resembling aspects of the human bAVM phenotype, displayed altered expression of the arterial and venous markers (EphB4 and Jagged-1), and showed evidence of arteriovenous shunting. Vascular irregularities were not seen in similarly treated WT mice.
Interpretation: Our data indicate that postnatal, adult formation of the human disease, bAVM, is possible, and that both genetic mutation and angiogenic stimulation are necessary for lesion development. Our work not only provides a testable adult mouse bAVM model for the first time, but also suggests that specific medical therapy can be developed to slow bAVM growth and potentially stabilize the rupture-prone abnormal vasculature.
Copyright © 2011 American Neurological Association.
Figures
Similar articles
-
Minimal homozygous endothelial deletion of Eng with VEGF stimulation is sufficient to cause cerebrovascular dysplasia in the adult mouse.Cerebrovasc Dis. 2012;33(6):540-7. doi: 10.1159/000337762. Epub 2012 May 9. Cerebrovasc Dis. 2012. PMID: 22571958 Free PMC article.
-
Integrin β8 Deletion Enhances Vascular Dysplasia and Hemorrhage in the Brain of Adult Alk1 Heterozygous Mice.Transl Stroke Res. 2016 Dec;7(6):488-496. doi: 10.1007/s12975-016-0478-2. Epub 2016 Jun 29. Transl Stroke Res. 2016. PMID: 27352867 Free PMC article.
-
Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain.Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):305-10. doi: 10.1161/ATVBAHA.112.300485. Epub 2012 Dec 13. Arterioscler Thromb Vasc Biol. 2013. PMID: 23241407 Free PMC article.
-
Vascular Integrity in the Pathogenesis of Brain Arteriovenous Malformation.Acta Neurochir Suppl. 2016;121:29-35. doi: 10.1007/978-3-319-18497-5_6. Acta Neurochir Suppl. 2016. PMID: 26463919 Free PMC article. Review.
-
Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.Clin Med Res. 2006 Mar;4(1):66-78. doi: 10.3121/cmr.4.1.66. Clin Med Res. 2006. PMID: 16595794 Free PMC article. Review.
Cited by
-
Hereditary hemorrhagic telangiectasia: from signaling insights to therapeutic advances.J Clin Invest. 2024 Feb 15;134(4):e176379. doi: 10.1172/JCI176379. J Clin Invest. 2024. PMID: 38357927 Free PMC article. Review.
-
Current perspectives and trends in the treatment of brain arteriovenous malformations: a review and bibliometric analysis.Front Neurol. 2024 Jan 11;14:1327915. doi: 10.3389/fneur.2023.1327915. eCollection 2023. Front Neurol. 2024. PMID: 38274874 Free PMC article.
-
Increased Collagen I/Collagen III Ratio Is Associated with Hemorrhage in Brain Arteriovenous Malformations in Human and Mouse.Cells. 2024 Jan 1;13(1):92. doi: 10.3390/cells13010092. Cells. 2024. PMID: 38201296 Free PMC article.
-
The Role and Therapeutic Implications of Inflammation in the Pathogenesis of Brain Arteriovenous Malformations.Biomedicines. 2023 Oct 24;11(11):2876. doi: 10.3390/biomedicines11112876. Biomedicines. 2023. PMID: 38001877 Free PMC article. Review.
-
Understanding the pathogenesis of brain arteriovenous malformation: genetic variations, epigenetics, signaling pathways, and immune inflammation.Hum Genet. 2023 Dec;142(12):1633-1649. doi: 10.1007/s00439-023-02605-6. Epub 2023 Sep 28. Hum Genet. 2023. PMID: 37768356 Review.
References
-
- Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet. 2002;359:863–873. - PubMed
-
- Mullan S, Mojtahedi S, Johnson DL, Macdonald RL. Embryological basis of some aspects of cerebral vascular fistulas and malformations. J Neurosurg. 1996;85:1–8. - PubMed
-
- Kim H, Sidney S, McCulloch CE, et al. Racial/ethnic differences in longitudinal risk of intracranial hemorrhage in brain arteriovenous malformation patients. Stroke. 2007;38:2430–2437. - PubMed
-
- Kim H, Pawlikowska L, Young WL. Genetics and vascular biology of brain vascular malformations. In: Mohr JP, Wolf PA, Grotta JC, et al., editors. Stroke: Pathophysiology, Diagnosis, and Management. 5th ed. Philadelphia: Churchill Livingstone Elsevier; 2010.
Publication types
MeSH terms
Substances
Grants and funding
- R01-HL64024/HL/NHLBI NIH HHS/United States
- R01 HL064024/HL/NHLBI NIH HHS/United States
- R21 NS070153/NS/NINDS NIH HHS/United States
- P01 NS044155/NS/NINDS NIH HHS/United States
- R01 NS027713/NS/NINDS NIH HHS/United States
- R01-NS27713/NS/NINDS NIH HHS/United States
- R01 HL064024-10/HL/NHLBI NIH HHS/United States
- R01 NS027713-09/NS/NINDS NIH HHS/United States
- P01 NS044155-08/NS/NINDS NIH HHS/United States
- R21 NS070153-01/NS/NINDS NIH HHS/United States
- R21-NS070153/NS/NINDS NIH HHS/United States
- P01-NS44155/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
